ANDROSTA-1,4-DIENE-17-CARBOTHIOIC ACID, 6,9-DIFLUORO-17-((2-FURANYLCARBONYL)OXY)-11-HYDROXY-16-METHYL-3-OXO-, ANHYDROSULFIDE WITH 2-FURANCARBOTHIOIC ACID, (6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-
UNII D24VPX3KH4
Substance Identification & Data
This profile provides standardized clinical and technical data for Androsta-1,4-diene-17-carbothioic Acid, 6,9-difluoro-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methyl-3-oxo-, Anhydrosulfide With 2-furancarbothioic Acid, (6.alpha.,11.beta.,16.alpha.,17.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D24VPX3KH4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 397864-41-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H30F2O8S IDGOYTOOZUPXJS-BLIQBSBASA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Androsta-1,4-diene-17-carbothioic Acid, 6,9-difluoro-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methyl-3-oxo-, Anhydrosulfide With 2-furancarbothioic Acid, (6.alpha.,11.beta.,16.alpha.,17.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.